PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross Blue Shield of VermontCommercial · Coverage · Pharmacy · VT · Pharmacy, Cardiology, Gastroenterology +12 moreHigh impact

Pharmacy Updates

Act
by Dec 15, 2026
Effective date
Jan 1, 2027
Identified
Sep 30, 2026

Summary

Effective January 1, 2027, this NPF formulary update removes 60+ brand-name drugs from coverage, uptiers 3 medications to require generic alternatives, adds step therapy to Gemtesa, implements quantity limits on diabetic test strips/insulin pumps, and removes Viread from the Health Care Reform List. Billing teams must immediately identify affected patients, update prior authorization workflows, and prepare claims adjustments for the January 1 effective date.

Get alerts when payers change rules like this one

We check Blue Cross Blue Shield of Vermont and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross Blue Shield of Vermont alertsPolicy Monitoring is free. No card required.

What to do

by Dec 15, 2026 · 8 steps
01Billing team must audit active patient medication lists in the EHR/billing system to identify any patients currently on the 60+ excluded medications (e.g., Januvia, Entresto, Saxenda, Revlimid, Xeljanz, Harvoni, Epclusa, Sovaldi, OxyContin, Avanafil, Captopril, Cimetidine, Horizant, Ketoprofen, and others listed).
02For each affected medication, verify whether the patient is mid-treatment (applies to Harvoni, Epclusa, Sovaldi—which allow continuation) or requires immediate switching.
03Update billing software to flag claims containing excluded medications and automatically require generic/alternative substitution codes.
04Add Gemtesa step therapy requirement: system must validate that patients have failed at least two of the listed anticholinergics (darifenacin ER, fesoterodine ER, oxybutynin IR/ER, solifenacin, tolterodine IR/ER, trospium IR/ER, mirabegron) before approving coverage.
05Implement quantity limits in billing system: diabetic test strips (100/month without insulin, 300/month with insulin), Omnipod (10 pods/month), PEG-based bowel prep (2 kits/year), Twist refill kits (1/month).
06Notify providers of Viread removal from HCR list and update encounter templates to inform patients of increased cost-share effective January 1, 2027.
07Prepare denial/appeal response templates for claims submitted on or after January 1, 2027 containing excluded medications.
08Claims will be denied automatically unless prior authorization for alternatives is obtained in advance.

Original notice

Pharmacy Updates
bluecrossvt.org · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account